{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:35:58Z","timestamp":1794659758181,"version":"4.9.1"},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The spondyloarthopathies (SpA), which encompass related diseases that were originally viewed as autoimmune, are now known to have a strong innate immune or autoinflammatory initiation phase characterized by disease localization to tissue-specific sites based on the nuances and microanatomy and immunology of those sites. This review covers recent translational advances in the field of SpA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Imaging studies in SpA continue to add support for the pivotal role of enthesitis in disease initiation and expression. Although in its infancy, there is growing evidence for microbiotal intestinal dysbiosis in ankylosing spondylitis and psoriatic arthritis. The role of cytokines beyond tumour necrosis factor (TNF) continues to grow with support for the interleukin (IL)-23\/17 axis being key to disease and emergent evidence for the importance of the IL-36 pathway. The treatment of inflammatory bowel disease (IBD) with vedolizumab an \u03b14\u03b27-integrin blocker has been associated with arthritis flares and small molecules with Janus kinase inhibition appear to be as effective as the anti-TNFs. The disparate response of different domains in SpA points towards immunological heterogeneity even within what was considered a homogeneous disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>The clinical aspects and translational immunology and therapeutics of SpA continue to evolve and indicate the complexity of diagnosis and treatment of these conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000529","type":"journal-article","created":{"date-parts":[[2018,6,10]],"date-time":"2018-06-10T13:24:22Z","timestamp":1528637062000},"page":"526-532","source":"Crossref","is-referenced-by-count":34,"title":["Spondyloarthritis: new insights into clinical aspects, translational immunology and therapeutics"],"prefix":"10.1097","volume":"30","author":[{"given":"Charlie","family":"Bridgewood","sequence":"first","affiliation":[{"name":"Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla","family":"Watad","sequence":"additional","affiliation":[{"name":"Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK"},{"name":"Department of Medicine \u2019B\u2019, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Cuthbert","sequence":"additional","affiliation":[{"name":"Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[{"name":"Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrrheum.2012.33","article-title":"Diagnosis and classification in spondyloarthritis: identifying a chameleon","volume":"8","author":"van Tubergen","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","article-title":"Enthesitis: from pathophysiology to treatment","volume":"13","author":"Schett","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"R4-20230829","article-title":"The clinical utility of human leucocyte antigen B27 in axial spondyloarthritis","author":"Lim","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2040622317743486","article-title":"New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice","volume":"9","author":"Dubash","year":"2018","journal-title":"Ther Adv Chronic Dis"},{"key":"R6-20230829","first-page":"708","article-title":"Lessons learned from imaging on enthesitis in psoriatic arthritis","volume":"19","author":"Watad","year":"2017","journal-title":"Isr Med Assoc J"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/annrheumdis-2017-212681","article-title":"\u2019Deep Koebner\u2019 phenomenon of the flexor tendon-associated accessory pulleys as a novel factor in tenosynovitis and dactylitis in psoriatic arthritis","volume":"77","author":"Tinazzi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R8-20230829","article-title":"Comprehensive evaluation of finger flexor tendon entheseal soft tissue and bone changes by ultrasound can differentiate psoriatic arthritis and rheumatoid arthritis","author":"Tinazzi","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203946","article-title":"Quantitative syndesmophyte measurement in ankylosing spondylitis using CT: longitudinal validity and sensitivity to change over 2 years","volume":"74","author":"Tan","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3899\/jrheum.170171","article-title":"Short-term repeat magnetic resonance imaging scans in suspected early axial spondyloarthritis are clinically relevant only in HLA-B27-positive male subjects","volume":"45","author":"Sengupta","year":"2018","journal-title":"J Rheumatol"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"e0189569","DOI":"10.1371\/journal.pone.0189569","article-title":"Bone edema on magnetic resonance imaging is highly associated with low bone mineral density in patients with ankylosing spondylitis","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"e000127","DOI":"10.1136\/bmjgast-2016-000127","article-title":"Combination therapy with vedolizumab and etanercept in a patient with pouchitis and spondylarthritis","volume":"4","author":"Bethge","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ecco-jcc\/jjx142","article-title":"Co-treatment with golimumab and vedolizumab to treat severe UC and associated spondyloarthropathy","volume":"12","author":"Roblin","year":"2018","journal-title":"J Crohns Colitis"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/bjd.14270","article-title":"Combination of antitumour necrosis factor-alpha and antiinterleukin-12\/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study","volume":"174","author":"Gniadecki","year":"2016","journal-title":"Br J Dermatol"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/annrheumdis-2016-209831","article-title":"A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1136\/annrheumdis-2015-209068","article-title":"Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: posthoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1\/PSUMMIT-2)","volume":"75","author":"Kavanaugh","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"(suppl 2)","key":"R17-20230829","article-title":"OP0218 efficacy and safety results of guselkumab, an antiil23 monoclonal antibody, in patients with active psoriatic arthritis over 24 weeks: a phase 2a, randomized, double-blind, placebo-controlled study. [Oral presentation]","volume":"76.","author":"Deodhar","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40744-016-0031-5","article-title":"Secukinumab: a new treatment option for psoriatic arthritis","volume":"3","author":"Mease","year":"2016","journal-title":"Rheumatol Ther"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","article-title":"Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1","volume":"76","author":"Mease","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/annrheumdis-2017-212127","article-title":"Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation","volume":"77","author":"Glatt","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJMoa1615975","article-title":"Tofacitinib or adalimumab versus placebo for psoriatic arthritis","volume":"377","author":"Mease","year":"2017","journal-title":"N Engl J Med"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1615977","article-title":"Tofacitinib for psoriatic arthritis in patients with an inadequate response to TNF inhibitors","volume":"377","author":"Gladman","year":"2017","journal-title":"N Engl J Med"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1759720X16673786","article-title":"Apremilast in the treatment of psoriatic arthritis: a perspective review","volume":"9","author":"Reed","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/BOR.0000000000000274","article-title":"New therapies for psoriasis and psoriatic arthritis","volume":"28","author":"Ritchlin","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13075-017-1249-5","article-title":"Mechanistic rationales for targeting interleukin-17A in spondyloarthritis","volume":"19","author":"Raychaudhuri","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10067-015-2961-7","article-title":"Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis","volume":"34","author":"Raychaudhuri","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","article-title":"The IL-23-IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ni.3726","article-title":"IL-17(+) gammadelta T cells as kick-starters of inflammation","volume":"18","author":"Papotto","year":"2017","journal-title":"Nat Immunol"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"IL-23-IL-17 immune axis: discovery, mechanistic understanding, and clinical testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/cei.12376","article-title":"Interleukin (IL)-17A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis","volume":"177","author":"Sarkar","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","article-title":"Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response","volume":"13","author":"Appel","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng.513","article-title":"Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci","volume":"42","author":"Reveille","year":"2010","journal-title":"Nat Genet"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/ard.2010.133322","article-title":"Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese","volume":"70","author":"Davidson","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R35-20230829","first-page":"6","article-title":"IL23R gene variants in relation to IL17A levels and clinical phenotype in patients with ankylosing spondylitis","volume":"2","author":"Nossent","year":"2018","journal-title":"Rheumatol Adv Pract"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","article-title":"Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis","volume":"30","author":"Mei","year":"2011","journal-title":"Clin Rheumatol"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.39261","article-title":"Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid","volume":"67","author":"Leijten","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/art.38376","article-title":"Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression","volume":"66","author":"Menon","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"(1\u20132)","key":"R39-20230829","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11010-011-1036-6","article-title":"IL-17 receptor and its functional significance in psoriatic arthritis","volume":"359","author":"Raychaudhuri","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00011-012-0509-8","article-title":"Association of IL23R polymorphisms with psoriasis and psoriatic arthritis: a meta-analysis","volume":"61","author":"Zhu","year":"2012","journal-title":"Inflamm Res"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/ar3817","article-title":"Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features","volume":"14","author":"Celis","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/eji.201546095","article-title":"A novel IL-23p19\/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice","volume":"46","author":"Wang","year":"2016","journal-title":"Eur J Immunol"},{"key":"R43-20230829","first-page":"1660","article-title":"Anti-IL-39\u200a(IL-23p19\/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupus-like mice","volume":"17","author":"Wang","year":"2018","journal-title":"Mol Med Rep"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1189\/jlb.3RI1014-495R","article-title":"Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions","volume":"97","author":"Gabay","year":"2015","journal-title":"J Leukoc Biol"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"E2748","DOI":"10.1073\/pnas.1620954114","article-title":"Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36\u03b3","volume":"114","author":"Ainscough","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MIB.0000000000000654","article-title":"Increased expression of interleukin-36, a member of the interleukin-1 cytokine family, in inflammatory bowel disease","volume":"22","author":"Nishida","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1681\/ASN.2016080840","article-title":"IL-36 signaling facilitates activation of the NLRP3 inflammasome and IL-23\/IL-17 axis in renal inflammation and fibrosis","volume":"28","author":"Chi","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/gutjnl-2015-310374","article-title":"IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo","volume":"66","author":"Scheibe","year":"2017","journal-title":"Gut"},{"key":"R50-20230829","first-page":"OA4846","article-title":"Late Breaking Abstract-IL-36 receptor agonists contribute to a pro-inflammatory milieu in smokers with and without COPD","volume":"50","author":"Kovach","year":"2017","journal-title":"Eur Respir J"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.jdermsci.2016.08.017","article-title":"Macrophages regulate IL-17-associated skin inflammation in mice with Dlx3-deficient keratinocytes","volume":"84","author":"Ogawa","year":"2016","journal-title":"J Dermatol Sci"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/mi.2016.107","article-title":"IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia","volume":"10","author":"Aoyagi","year":"2017","journal-title":"Mucosal Immunol"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00403-017-1769-5","article-title":"IL-36 cytokines are increased in acne and hidradenitis suppurativa","volume":"309","author":"Di Caprio","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/jid.2011.234","article-title":"Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis","volume":"131","author":"Carrier","year":"2011","journal-title":"J Invest Dermatol"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","article-title":"IL-36R ligands are potent regulators of dendritic and T cells","volume":"118","author":"Vigne","year":"2011","journal-title":"Blood"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fimmu.2018.00200","article-title":"IL-36\u03b3 is a strong inducer of IL-23 in psoriatic cells and activates angiogenesis","volume":"9","author":"Bridgewood","year":"2018","journal-title":"Front Immunol"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cyto.2013.06.256","article-title":"253: IL-36 induces inflammation and collagen deposition in the lung","volume":"63","author":"Sun","year":"2013","journal-title":"Cytokine"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"pii: eaan2514","DOI":"10.1126\/scitranslmed.aan2514","article-title":"An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target","volume":"9","author":"Mahil","year":"2017","journal-title":"Sci Transl Med"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.4049\/jimmunol.1300047","article-title":"IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production","volume":"192","author":"Teng","year":"2014","journal-title":"J Immunol"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/annrheumdis-2016-210630","article-title":"IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro","volume":"76","author":"Boutet","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R61-20230829","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/rheumatology\/kew325","article-title":"Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation","volume":"55","author":"Cavalli","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R62-20230829","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1073\/pnas.1121534109","article-title":"IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist","volume":"109","author":"van de Veerdonk","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R63-20230829","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni.3103","article-title":"IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction","volume":"16","author":"Nold-Petry","year":"2015","journal-title":"Nat Immunol"},{"key":"R64-20230829","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/art.21928","article-title":"Association between the interleukin-1 family gene cluster and psoriatic arthritis","volume":"54","author":"Rahman","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R65-20230829","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/ard.2005.046847","article-title":"Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese","volume":"65","author":"Chou","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R66-20230829","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1744-313X.2009.00889.x","article-title":"Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han population","volume":"37","author":"Guo","year":"2010","journal-title":"Int J Immunogenet"},{"key":"R67-20230829","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.40183","article-title":"Intestinal metabolites are profoundly altered in the context of HLA-B27 expression and functionally modulate disease in a rat model of spondyloarthritis","volume":"69","author":"Asquith","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R68-20230829","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/annrheumdis-2016-211064","article-title":"Faecal microbiota study reveals specific dysbiosis in spondyloarthritis","volume":"76","author":"Breban","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R69-20230829","first-page":"2273","article-title":"The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"key":"R70-20230829","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.38967","article-title":"Brief report: intestinal dysbiosis in ankylosing spondylitis","volume":"67","author":"Costello","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R71-20230829","doi-asserted-by":"crossref","first-page":"pii: E2126","DOI":"10.3390\/ijms17122126","article-title":"A possible role of intestinal microbiota in the pathogenesis of ankylosing spondylitis","volume":"17","author":"Yang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R72-20230829","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/rheumatology\/41.12.1395","article-title":"Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis","volume":"41","author":"Stebbings","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R73-20230829","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s10067-006-0488-7","article-title":"Ankylosing spondylitis is linked to Klebsiella: the evidence","volume":"26","author":"Rashid","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R74-20230829","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/MEG.0b013e328318ecde","article-title":"Role of Klebsiella and collagens in Crohn's disease: a new prospect in the use of low-starch diet","volume":"21","author":"Rashid","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R75-20230829","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.38892","article-title":"Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease","volume":"67","author":"Scher","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R76-20230829","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.40359","article-title":"Gut microbiota perturbations in reactive arthritis and postinfectious spondyloarthritis","volume":"70","author":"Manasson","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R77-20230829","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000233289","article-title":"Joint extraintestinal manifestations in ulcerative colitis","volume":"27","author":"Dorofeyev","year":"2009","journal-title":"Dig Dis"},{"key":"R78-20230829","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/art.40175","article-title":"Macrophage migration inhibitory factor induces inflammation and predicts spinal progression in ankylosing spondylitis","volume":"69","author":"Ranganathan","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R79-20230829","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/annrheumdis-2017-211989","article-title":"Low-dose CT detects more progression of bone formation in comparison to conventional radiography in patients with ankylosing spondylitis: results from the SIAS cohort","volume":"77","author":"de Koning","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R80-20230829","first-page":"488","article-title":"Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies","volume":"56","author":"El-Zayadi","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R81-20230829","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1038\/ncomms10928","article-title":"IL-17-producing \u03b3\u03b4 T cells enhance bone regeneration","volume":"7","author":"Ono","year":"2016","journal-title":"Nat Commun"},{"key":"R82-20230829","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bone.2016.01.010","article-title":"Proinflammatory T cells and IL-17 stimulate osteoblast differentiation","volume":"84","author":"Croes","year":"2016","journal-title":"Bone"},{"key":"R83-20230829","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11926-018-0751-3","article-title":"Enthesitis: much more than focal insertion point inflammation","volume":"20","author":"Watad","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"R84-20230829","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/art.40150","article-title":"Brief Report: Group 3 innate lymphoid cells in human enthesis","volume":"69","author":"Cuthbert","year":"2017","journal-title":"Arthritis Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201809000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T02:38:46Z","timestamp":1693276726000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201809000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000529","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733464342.793564280","asserted-by":"object"}]},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}